Cooperative Research and Development Agreement (CRADA) Opportunity and/or Licensing Opportunity for Materials and Methods for Protection of Tissue From Ischemic Damage

Riepilogo

The National Institutes of Health is seeking CRADA partners and/or licensees for the further development, evaluation, and commercialization of materials and methods for protecting tissues from cell injury by Ischemia. The invention claimed in U.S. Patent Application Serial No. 60/053,843, ``12(S)=HpETE (A 12=Lipoxygenase Metabolite) Significantly Reduces Cell Injury,'' is available for licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under one or more CRADAs in several clinically important applications as described below in the Supplementary Information.